New Zealand: Where Are We Going?

Chapter

Abstract

New Zealand is a small remote country with 4.4 million increasingly ethnically diverse inhabitants. There is a well-entrenched tradition of publicly funded social services including healthcare, education and welfare. Public expectations of the capabilities of the welfare state have become tempered in recent years by the legacy of the free-market reforms which began in the late 1980s and by the almost-stagnant economy which has yet to recover from the 2008 global recession. Per capita GDP at purchasing power parity is just over half that of the US. Health expenditure [1] is around 75 % of that in Australia, Canada and most of western Europe but only a third of US health expenditure. Publicly funded healthcare occupies a dominant position in health care with 81 % of expenditure being Government-funded [2]. Intensive care medicine (as it is known in New Zealand) is almost completely confined to the 25 ICUs in public hospitals [3]. Most of these are multi-disciplinary ICUs—only one is a speciality ICU (cardiovascular) and there is only one paediatric ICU. There are small intensive care units confined to post-surgical (mostly cardiac) patients in three private hospitals.

Keywords

Europe Pneumonia Meningitis Catecholamine Theophylline 

References

  1. 1.
    International Monetary Fund. World economic outlook database. Washington DC: International Monetary Fund. 2010. http://www.imf.org/external/pubs/ft/weo/2010/02/weodata/index.aspx. Accessed 16 Nov 2010.
  2. 2.
    The New Zealand Health and Disability System: Organisations and Responsibilities. Briefing to the Minister of Health. Wellington: Ministry of Health. 2008. http://www.moh.govt.nz/moh.nsf/pagesmh/8704/$File/nz-health-disability-system-briefing2008.doc. Accessed 16 Nov 2010.
  3. 3.
    Drennan K, Hart GK, Hicks P. Intensive care resources and activity: Australia and New Zealand 2006/2007. Melbourne: ANZICS. 2008. http://www.anzics.com.au/. Accessed 23 Nov 2010.
  4. 4.
    Verdon-Roe A, Gilbert J. The world of wings and things. New York: Arno Press; 1979.Google Scholar
  5. 5.
    Trubuhovich RV. August 26th 1952 at Copenhagen: ‘Bjørn Ibsen’s Day’; a significant event for anaesthesia. Acta Anaesthesiol Scand. 2004;48(3):272–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Spence M. The emergency treatment of acute respiratory failure. Anesthesiology. 1962;23: 524–37.PubMedCrossRefGoogle Scholar
  7. 7.
    Irvine RO, Montgomerie MB, Spence M. Assisted respiration, noradrenaline infusion and the artificial kidney for glutethimide (“Doriden”) poisoning. Med J Aust. 1963;2:277–9.PubMedGoogle Scholar
  8. 8.
    Trubuhovich RV. From respiratory support to critical care: my early days in intensive care medicine. Crit Care Resusc. 2007;9(2):123–6.Google Scholar
  9. 9.
    Eiseman B, Beart R, Norton L. Multiple organ failure. Surg Gynecol Obstet. 1977;144(3): 323–6.PubMedGoogle Scholar
  10. 10.
    Routh GS, Briggs JD, Mone JG, Ledingham IM. Survival from acute renal failure with and without multiple organ dysfunction. Postgrad Med J. 1980;56(654):244–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Leff B, Finucane TE. Gizmo idolatry. JAMA. 2008;299(15):1830–2.PubMedCrossRefGoogle Scholar
  12. 12.
    Zimmerman JE, Galler LG, Judson JA, Streat SJ, Trubuhovich RV. Severity stratification in life threatening asthma. J Intensive Care Med. 1990;5(3):120–7.CrossRefGoogle Scholar
  13. 13.
    Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic. Lancet. 1995;345(8941):41–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Parr MJ, Anaes FC, Day AC, Kletchko SL, Crone PD, Rankin AP. Theophylline poisoning – a review of 64 cases. Intensive Care Med. 1990;16(6):394–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Bellomo R, Goldsmith D, Uchino S, Buckmaster J, Hart G, Opdam H, Silvester W, Doolan L, Gutteridge G. A before and after trial of the effect of a high-dependency unit on post-operative morbidity and mortality. Crit Care Resusc. 2005;7(1):16–21.PubMedGoogle Scholar
  16. 16.
    Streat S. Improving the effectiveness of our practices. In: Flaatten H, Moreno R, Putensen C, Rhodes A, editors. Organisation and management of intensive care. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft; 2010.Google Scholar
  17. 17.
    Peters DA. An individualistic approach to routine cadaver organ removal. Health Prog. 1988;69:25–8.PubMedGoogle Scholar
  18. 18.
    Finarelli Jr HJ, Johnson T. Effective demand forecasting in 9 steps. Healthc Financ Manage. 2004;58(11):52–6.PubMedGoogle Scholar
  19. 19.
    Corke C, Leeuw E, Lo SK, George C. Predicting future intensive care demand in Australia. Crit Care Resusc. 2009;11(4):257–60.PubMedGoogle Scholar
  20. 20.
    Bagshaw SM, Webb SA, Delaney A, George C, Pilcher D, Hart GK, Bellomo R. Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care. 2009;13(2):R45.PubMedCrossRefGoogle Scholar
  21. 21.
    Hill AD, Fan E, Stewart TE, Sibbald WJ, Nauenberg E, Lawless B, Bennett J, Martin CM. Critical care services in Ontario: a survey-based assessment of current and future resource needs. Can J Anaesth. 2009;56(4):291–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Angus DC, Kelley MA, Schmitz RJ, White A, Popovich J Jr; Committee on Manpower for Pulmonary and Critical Care Societies (COMPACCS). Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population? JAMA. 2000;284(21):2762–70.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Critical Care MedicineAuckland City HospitalAucklandNew Zealand

Personalised recommendations